San Diego, California--(Newsfile Corp. - July 27, 2021) -  Mycrodose Therapeutics, a US-Based pharmaceutical company focused on developing advanced drug delivery systems for use with psychedelic compounds, announced today that its Executive team will be participating in the upcoming Psychedelic Capital Event on July 29, 2021. 

The virtual...